Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 24 February, 2024|Author: Getaka | Social: X Twitter Profile
Stock Ticker - BSE: 524394 | NSE: VIMTALABS

Fundamental Analysis of Vimta Labs Ltd

About the Company - Vimta Labs Ltd

Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977. Currently company belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 275.98 Cr. and Equity Capital is Rs. 4.42 Cr. for the Year ended 31/03/2022.
Hospitals & Medical ServicesPlot Nos. 141/2 & 142, IDA Phase II, Hyderabad Telangana
NamePosition Held
Dr. Sivalinga Prasad VasireddiNon Executive Chairman
Mr. Harita VasireddiManaging Director
Mr. Harriman VungalExecutive Director - Operations
Mr. Satya Sreenivas NeerukondaExecutive Director
Dr. Yadagiri R PendriIndependent Director
Mrs. Prameela Rani YalamanchiliIndependent Director
Mr. Sanjay DaveIndependent Director
Mr. Purnachandra Rao GuttaIndependent Director

Vimta Labs Ltd. Share Price Update

Share PriceValue
Previous Day₹490.90

Basic Stock Data of Vimta Labs Ltd

Market Cap 1,093 Cr.
Current Price 493
High / Low623/289
Stock P/E27.9
Book Value 133
Dividend Yield0.42 %
ROCE24.3 %
ROE18.4 %
Face Value 2.00

Data Source:

Competitors of Vimta Labs Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Apollo Hospitals Enterprise Ltd 97,184 Cr. 6,7596,874/4,168123 4530.22 %14.5 %13.7 % 5.00
Thyrocare Technologies Ltd 3,270 Cr. 617695/41552.8 89.22.92 %15.3 %10.6 % 10.0
Max India Ltd 842 Cr. 195234/76.0 1230.00 %0.53 %1.81 % 10.0
Aster DM Healthcare Ltd 23,315 Cr. 467487/21764.0 87.60.00 %9.21 %11.0 % 10.0
Shalby Ltd 3,175 Cr. 294340/11439.0 89.20.41 %10.6 %7.37 % 10.0
Industry Average193.6 Cr315.855.76168.40.71%10.03%8.9%9

Vimta Labs Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Operating Profit16.5816.6616.6919.6220.3923.0723.8425.1221.0223.5623.8415.3020.88
OPM %28.49%28.00%27.36%26.27%30.58%31.35%30.30%31.75%27.48%29.16%29.01%21.17%26.07%
Other Income0.300.240.18-1.090.720.420.900.771.130.670.592.040.89
Profit before tax10.5710.4310.9512.8115.3216.2816.5917.5613.7015.9815.547.8512.60
Tax %24.22%25.79%25.84%25.76%24.54%27.03%27.49%25.63%27.30%23.34%25.16%24.59%24.92%
Net Profit8.017.758.119.5111.5711.8812.0313.069.9612.2511.635.929.46
EPS in Rs3.623.513.674.305.235.375.445.914.505.545.252.674.27

Vimta Labs Ltd Quarterly Chart

Vimta Labs Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit1212617192745583053809484
OPM %1%19%20%15%14%18%25%27%17%25%29%30%26%
Other Income3131111231034
Profit before tax-1641878172635828556452
Tax %4%4%25%24%23%36%36%28%17%25%26%26%
Net Profit-1541356111625721414739
EPS in Rs-6.961.905.992.292.914.797.4311.453.139.6218.5721.3717.73
Dividend Payout %0%32%33%44%34%0%27%17%0%21%11%9%

Vimta Labs Ltd Profit & Loss Yearly Chart

YoY Net Profit Growth
YoY Net Profit Growth (%)126.67%225.00%-61.54%20.00%83.33%45.45%56.25%-72.00%200.00%95.24%14.63%
Change in YoY Net Profit Growth (%)0.00%98.33%-286.54%81.54%63.33%-37.88%10.80%-128.25%272.00%-104.76%-80.60%

Vimta Labs Ltd Growth

Compounded Sales Growth
10 Years:11%
5 Years:11%
3 Years:20%
Compounded Profit Growth
10 Years:27%
5 Years:24%
3 Years:91%
Stock Price CAGR
10 Years:25%
5 Years:19%
3 Years:42%
1 Year:52%
Return on Equity
10 Years:12%
5 Years:14%
3 Years:17%
Last Year:18%

Vimta Labs Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital4444444444444
Other Liabilities26212221234240403949546560
Total Liabilities156145149146176222232237245273306360374
Fixed Assets1059390888888140135131128162168174
Other Assets5151575882809299105122138174168
Total Assets156145149146176222232237245273306360374

Vimta Labs Ltd Reserves and Borrowings Chart

Vimta Labs Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 13161715-124333924375987
Cash from Investing Activity -4-4-8-8-16-39-24-16-20-32-38-57
Cash from Financing Activity -9-11-8-91913-8-23-1-5-16-11
Net Cash Flow-010-12-21131519

Vimta Labs Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days10787818210010111110011712810293
Inventory Days184165175158213183209199191140115187
Days Payable19314787667718414811511413981119
Cash Conversion Cycle98105169174236100172184194128136160
Working Capital Days5988841201266888871001169684
ROCE %-8%6%16%6%7%11%17%21%6%14%24%24%

Vimta Labs Ltd Financial Efficiency Indicators Chart

Vimta Labs Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
No. of Shareholders12,15220,92819,94719,19418,33218,10618,28318,91617,16217,43918,42919,957

Vimta Labs Ltd Shareholding Pattern Chart

No. of Vimta Labs Ltd Shareholders

Vimta Labs Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Quant Small Cap Fund3301520.114.99
Motilal Oswal S&P BSE Healthcare ETF780.040

Vimta Labs Ltd ROCE Trend

Vimta Labs Ltd EPS Trend

Vimta Labs Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20
Basic EPS (Rs.)21.7718.709.683.10
Diluted EPS (Rs.)21.3518.329.683.10
Cash EPS (Rs.)35.6529.2420.1212.56
Book Value[Excl.RevalReserv]/Share (Rs.)127.33105.8387.9278.19
Book Value[Incl.RevalReserv]/Share (Rs.)127.33105.8387.9278.19
Revenue From Operations / Share (Rs.)143.78125.8695.2981.73
PBDIT / Share (Rs.)44.4436.9724.3314.91
PBIT / Share (Rs.)30.5726.4213.895.44
PBT / Share (Rs.)29.3725.1912.913.74
Net Profit / Share (Rs.)21.7718.699.683.10
NP After MI And SOA / Share (Rs.)21.7718.699.683.10
PBDIT Margin (%)30.9129.3725.5218.24
PBIT Margin (%)21.2520.9814.576.65
PBT Margin (%)20.4220.0113.544.57
Net Profit Margin (%)15.1314.8510.163.78
NP After MI And SOA Margin (%)15.1314.8510.163.78
Return on Networth / Equity (%)17.0917.6611.013.95
Return on Capital Employeed (%)22.1722.5113.926.39
Return On Assets (%)13.2913.457.802.78
Long Term Debt / Equity (X)
Total Debt / Equity (X)
Asset Turnover Ratio (%)0.940.950.800.00
Current Ratio (X)2.862.602.051.67
Quick Ratio (X)2.462.241.781.37
Dividend Payout Ratio (NP) (%)9.1710.690.0064.60
Dividend Payout Ratio (CP) (%)5.606.830.0015.91
Earning Retention Ratio (%)90.8389.310.0035.40
Cash Earning Retention Ratio (%)94.4093.170.0084.09
Interest Coverage Ratio (X)37.1954.5624.818.76
Interest Coverage Ratio (Post Tax) (X)19.2129.4110.872.82
Enterprise Value (Cr.)670.65704.61372.30147.42
EV / Net Operating Revenue (X)2.112.531.770.81
EV / EBITDA (X)6.828.626.924.47
MarketCap / Net Operating Revenue (X)2.192.501.690.72
Retention Ratios (%)90.8289.300.0035.39
Price / BV (X)2.472.981.830.75
Price / Net Operating Revenue (X)2.192.501.690.72

Vimta Labs Ltd Profitability Ratios (%)

Vimta Labs Ltd Liquidity Ratios

Vimta Labs Ltd Liquidity Ratios (%)

Vimta Labs Ltd Interest Coverage Ratios (X)

Vimta Labs Ltd Valuation Ratios

Fair Value / Intrinsic Value of Vimta Labs Ltd

Fair Value: ₹685.64

The stock is undervalued by 39.07% compared to the current price ₹493

*Investments are subject to market risks

Strength and Weakness of Vimta Labs Ltd

  1. The company has higher reserves (166.92 cr) compared to borrowings (22.69 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (186.38 cr) and profit (23.54 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 19.08 and average Dividend Yield of 15.86%.
  2. The stock has a low average ROCE of 12.00%, which may not be favorable.
  3. The stock has a high average Working Capital Days of 93.00, which may not be favorable.
  4. The stock has a high average Cash Conversion Cycle of 154.67, which may not be favorable.

Should I Buy Vimta Labs Ltd Share Now?

  • Based on the analysis of various financial indicators, it may be worth considering investment in Vimta Labs Ltd:
    1. Net Profit Margin: 15.13% (Higher values are generally favorable)
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 22.17% (Industry Average ROCE: 11.19%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 19.21 (Higher values, preferably > 2, are recommended)
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 2.46 (Higher values, preferably > 1, are recommended)
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✓ Stock P/E: 27.1 (Industry average Stock P/E: 57.88)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✓ Total Debt / Equity: 0.05 (Lower values, preferably < 1, are preferred)
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    While these metrics suggest potential opportunity, it's essential to conduct thorough research or seek advice from financial experts before making any investment decisions.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Vimta Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE